Mediclinic Page 11

Getting latest data

Home / Special reports pages / Mediclinic Page 11

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Mediclinic Page 11

9) Mediclinic International (MDC)

Will shares pull back towards lows of 796p (-15%) or reach two year highs at 1220 (+30%)?

Has maintained post-Brexit breakout
Potential bounce at 925p intersecting support?
Some technicals oversold

Broker Consensus: 22% Buy, 56% Hold, 22% Sell

Bullish: Investec, Buy, Target 1100p, +17% (27 Sept)

Average Target: 984p, +5% (30 Sept)

Bearish: Goldman Sachs, Sell, Target 770p, -18% (28 Sept)

N.B. All pricing and consensus data was sourced from Bloomberg on 30 Sept. Recommendations and target prices are revised regularly due to heightened market volatility. Please contact us for a full, up to date rundown.

« Back to Category

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.

Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research

Comments are closed.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.

About Us

Accendo Markets is an award-winning provider of CFD and spread betting trading services. We provide an execution-only service.

Get in Touch

Quick Links

Telephone calls and online chat conversations may be monitored and recorded for regulatory and training purposes.

* We provide these as underlying assets to CFDs and Spreadbets.

To view our policies and terms, please click here

This website is not intended for or directed at residents of the United States or any country outside the UK. It is not intended for use by or distribution to any person in any jurisdiction or country where its use or distribution would contravene any regulation or local law.
Prices on this page are delayed.

Like many websites, we use cookies for statistical purposes and to acquire information on general internet use. This helps ensure that you get the full benefit of our services, and enhances your browsing experience . For more details on the cookies we use, view our privacy policy under the heading 'How We Use Cookies'. By using this website, we'll assume that you're happy to receive all cookies from Accendo Markets.
Removing cookies may impede the operation of some parts of this website. For general information about cookies and how to remove them, please click here

Accendo Markets Ltd - Highstone House, 165 High Street, Barnet EN5 5SU (UK) Telephone: 020 3051 7461 - Accendo Markets Ltd. is Authorised and Regulated by the Financial Conduct Authority (FCA) No. 475285. Accendo Markets Ltd. Registered in England and Wales No. 6417051. © Copyright Accendo Markets Ltd 2015. All rights reserved.